Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: BAYER

Market Cap 37.17B 42.64B 34.43B 32.23B 60.45B 4,023B 60.81B 408B 158B 1,980B 160B 157B 6,876B P/E 2026 *
16.1x
P/E 2027 * 12.1x
Enterprise Value 68.87B 78.99B 63.79B 59.71B 112B 7,453B 113B 757B 293B 3,669B 297B 290B 12,739B EV / Sales 2026 *
1.51x
EV / Sales 2027 * 1.41x
Free-Float
100%
Yield 2026 *
0.58%
Yield 2027 * 1.96%
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 66 01/04/2022
Director/Board Member 60 01/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-3.04%+44.03%+143.07% 980B
-2.48%-5.18%+52.47%+39.15% 550B
-2.14%-4.94%+16.83%+57.08% 382B
+0.25%-3.09%+23.33%+16.04% 316B
+0.61%-1.69%+27.35%+13.73% 272B
+0.22%-3.10%+24.67%+30.49% 268B
+4.59%+1.98%-38.43%-46.26% 199B
-1.19%-4.95%+16.68%+47.69% 182B
-1.35%-1.46%+14.06%+59.26% 154B
Average -0.30%-3.02%+20.11%+40.03% 366.93B
Weighted average by Cap. -0.78%-3.68%+29.49%+63.31%

Financials

2026 *2027 *
Net sales 45.54B 52.23B 42.18B 39.48B 74.05B 4,928B 74.5B 500B 194B 2,426B 196B 192B 8,423B 46.81B 53.69B 43.35B 40.58B 76.11B 5,066B 76.57B 514B 199B 2,493B 202B 197B 8,658B
Net income 2.17B 2.49B 2.01B 1.88B 3.53B 235B 3.55B 23.86B 9.25B 116B 9.35B 9.15B 402B 3B 3.44B 2.77B 2.6B 4.87B 324B 4.9B 32.92B 12.76B 160B 12.9B 12.62B 554B
Net Debt 31.7B 36.35B 29.36B 27.48B 51.54B 3,430B 51.85B 348B 135B 1,688B 136B 134B 5,863B 28.63B 32.83B 26.51B 24.82B 46.55B 3,098B 46.83B 315B 122B 1,525B 123B 121B 5,295B
Logo BAYER
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!